BIOMAKERS secures $8M funding to expand precision oncology platform, speeding up drug and diagnostic progress.
BIOMAKERS secures $8M funding to expand precision oncology platform, speeding up drug and diagnostic progress.
Unusual Whales
In San Francisco, BIOMAKERS has secured an extra $8 million in funding to expand its AI-driven precision oncology platform. This investment will aid in speeding up the progress of drug and diagnostic creation for the company.
